Krausz, M., Uhlmann, A., Rump, I.C., Ihorst, G., Goldacker, S., Sogkas, G., Posadas-Cantera, S., Schmidt, R., Feißt, M., Alsina, L., Dybedal, I., Recher, M., Warnatz, K. und Grimbacher, B. (2022) The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial [cd]. Freiburg: Universität. doi:10.1016/j.conctc.2022.101008.
Chicago Manual of Style 17th edition (full note)Krausz, Máté, Annette Uhlmann, Ina Caroline Rump, Gabriele Ihorst, Sigune Goldacker, Georgios Sogkas, Sara Posadas-Cantera, Reinhold Schmidt, Manuel Feißt, Laia Alsina, Ingunn Dybedal, Mike Recher, Klaus Warnatz, und Bodo Grimbacher. The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial. Cd. Freiburg: Universität, [2022?], Freiburg: Universität, [2022?]. https://doi.org/10.1016/j.conctc.2022.101008.
American Psychological Association 7th editionKrausz, M., Uhlmann, A., Rump, I. C., Ihorst, G., Goldacker, S., Sogkas, G., Posadas-Cantera, S., Schmidt, R., Feißt, M., Alsina, L., Dybedal, I., Recher, M., Warnatz, K., & Grimbacher, B. (ca. 2022). The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial [Cd]. Universität. https://doi.org/10.1016/j.conctc.2022.101008
Modern Language Association 9th editionKrausz, M., A. Uhlmann, I. C. Rump, G. Ihorst, S. Goldacker, G. Sogkas, S. Posadas-Cantera, R. Schmidt, M. Feißt, L. Alsina, I. Dybedal, M. Recher, K. Warnatz, und B. Grimbacher. The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial. cd, Universität, 2022, https://doi.org/10.1016/j.conctc.2022.101008.
ISO-690 (author-date, Deutsch)KRAUSZ, Máté, Annette UHLMANN, Ina Caroline RUMP, Gabriele IHORST, Sigune GOLDACKER, Georgios SOGKAS, Sara POSADAS-CANTERA, Reinhold SCHMIDT, Manuel FEISST, Laia ALSINA, Ingunn DYBEDAL, Mike RECHER, Klaus WARNATZ und Bodo GRIMBACHER, 2022. The ABACHAI clinical trial protocol: Safety and efficacy of abatacept (s.c.) in patients with CTLA-4 insufficiency or LRBA deficiency: A non controlled phase 2 clinical trial. Freiburg: Universität